NeuroLeap Capital
NeuroLeap Capital is a Pre-Seed, Seed venture capital firm based in New York, NY investing in Other, Healthcare, AI / ML. The firm typically writes $300K–$2.5M checks and has 3 portfolio companies in our records.
Pre-Seed, Seed
$300K – $2.5M
3+ companies
2 partners
Investment Thesis
An emerging fund investing in mental health and neuroscience-focused AI platforms for workplaces.
How NeuroLeap Capital invests
NeuroLeap Capital is a vc firm based in New York, NY. The firm invests at the Pre-Seed, Seed stages, with a focus on Other, Healthcare, AI / ML, Developer Tools. It does not invest in EdTech.
NeuroLeap Capital typically writes checks of $300K–$2.5M per investment.
NeuroLeap Capital has backed 3 companies in our records, including EmotionAI Labs, WellMetrics, NeuroLeap.
Meet the Team
Industry Focus
Invests In
Does Not Invest In
Portfolio Companies (3)
Other
EmotionAI Labs
WellMetrics
NeuroLeap
A health-tech / neuroscience company using brain-computer interface (BCI) technology for brain enhancement and mental health.
- •Raising at Pre-Seed, Seed? You're squarely in their sweet spot.
- •Lead with your fit in Other, Healthcare, AI / ML — the sectors they actively back.
- •Size your ask to their typical $300K – $2.5M check.
- •cold outreach ok
- •Address your outreach to a specific partner, such as David Sloan, Founder & GP.
- •A warm introduction beats a cold email. Get matched and request an intro.
Featured In
Browse More Investors
Fundraising resources
Frequently Asked Questions
See if NeuroLeap Capital is a match for your startup
Upload your pitch deck to see how well you match with NeuroLeap Capital and 10,000+ other investors.
Is this your profile? Request a correction or removal